Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [01/16/2026 15:52 PST] Passage Bio, Inc. (NASDAQ:PASG), Down By 100% ($15.16) From $15.16 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [01/15/2026 07:03 PST] PASG Expected to Trade Down After Bearish Patterns Develop
• [01/09/2026 12:04 PST] Passage Bio, Inc. (NASDAQ:PASG), Up By 100% ($16.4) From $16.4 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/07/2026 07:16 PST] PASG Expected to Trade Up After Bullish Patterns Develop
• [01/05/2026 21:20 PST] Market Maker Surveillance Report. PASG, Winning Stocks With Lowest Price Friction For Monday, January 5th 2026
• [01/05/2026 10:29 PST] Passage Bio, Inc. (NASDAQ:PASG), Up By 100% ($10.86) From $10.86 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/05/2026 10:29 PST] Passage Bio, Inc. (NASDAQ:PASG), Up By 100% ($11.69) From $11.69 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [01/05/2026 07:12 PST] PASG Expected to Trade Up After Bullish Patterns Develop
• [12/31/2025 13:20 PST] Passage Bio, Inc. (NASDAQ:PASG), Up By 100% ($9.99) From $9.99 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [12/29/2025 12:04 PST] Passage Bio, Inc. (NASDAQ:PASG), Up By 100% ($9.8) From $9.795 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [12/29/2025 07:16 PST] PASG Expected to Trade Up After Bullish Patterns Develop
• [12/24/2025 11:07 PST] Passage Bio, Inc. (NASDAQ:PASG), Up By 100% ($9.59) From $9.59 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [12/23/2025 07:48 PST] PASG Expected to Trade Up After Bullish Patterns Develop
• [12/22/2025 07:28 PST] PASG Expected to Trade Up After Bullish Patterns Develop
• [12/15/2025 05:59 PST] PASG Expected to Trade Up After Bullish Patterns Develop
• [12/10/2025 06:53 PST] PASG Expected to Trade Up After Bullish Patterns Develop